Document is current

Article History

Accepted: 6 January 2025

First Online: 7 February 2025

Declarations

:

: This work, medical writing assistance for the development of this article and the Open Access Fee was funded by Sanofi, Italy.

: Maria Esposito has served as a speaker or board member for AbbVie, Almirall, Amgen, Eli Lilly, LEO Pharma, Janssen, Novartis, Pfizer, Sanofi and UCB. Maria Concetta Fargnoli has served as an advisory board member for AbbVie, LEO Pharma, Novartis and Sanofi. Caterina Foti has acted as a speaker, consultant and advisory board member for AbbVie, Amgen, LEO Pharma, Novartis and Sanofi. Giampiero Girolomoni has served on boards for, received research grants from and received personal fees/honoraria for lectures from AbbVie, Almirall, Amgen, Bristol Myers Squibb, Boehringer Ingelheim, Eli Lilly, Galderma, Janssen, LEO Pharma, Merck Serono, Novartis, Pfizer, Pierre Fabre, Samsung Bioepis and Sanofi. Paolo Matruglio and Elena Nicoli are employees of Sanofi and may hold shares and/or stock options in the company. Maddalena Napolitano has acted as speaker, consultant and advisory board member for AbbVie, Amgen, Eli Lilly, LEO Pharma, Pierre Fabre and Sanofi. Paolo Romita declares no potential conflict of interest.

: Not applicable.

: Not applicable.

: Not applicable.

: Data sharing is not applicable to this article as no datasets were generated or analysed during the current study.

: Not applicable.

: M.N., M.E., M.C.F., G.G., P.R. and C.F. contributed to review conception. All authors contributed to the selection of the literature. All authors critically revised the manuscript for intellectual content between drafts and approved the final version for publication.